Showing results (361-370 of 509) with videos related to
Sort By:
Pageof 51
Controlled Clinical Trials|April 1, 1990
Analysis of the costs of a large prevention trialN Urban, S Self, L Kessler, et al.Thrombosis Research|January 1, 1982
Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgeryJ J Belch, D R Meek, G D Lowe, et al.Thrombosis and Haemostasis|February 29, 1980
Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemiaG D Lowe, M M Drummond, J L Third, et al.Experimental Neurology|November 5, 2003
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's diseaseD J Brooks, K A Frey, K L Marek, et al.Controlled Clinical Trials|June 1, 1988
Statistical design of the Women's Health TrialS Self, R Prentice, D Iverson, et al.The Journal of Knee Surgery|February 22, 2021
Lumbar Spine Sagittal Mismatch Deformity Negatively Affects Total Knee Arthroplasty OutcomesWilliam L Sheppard, Alexander Upfill-Brown, Kevin M McKay, et al.Stroke|February 1, 1994
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic strokeD E Levy, T G Brott, E C Haley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?Alison Kent, Ashley Makwana, Carmen L Sheppard, et al.British Journal of Clinical Pharmacology|January 1, 1983
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trialJ J Belch, J Cormie, P Newman, et al.Lancet (London, England)|February 12, 1983
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trialJ J Belch, A McKay, B McArdle, et al.Pageof 51